SCHEMBL6869656

SCHEMBL6869656

FC(F)(F)c1cc(Cl)c(-n2cnc(I)n2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 7/20 0.47
GABRB2 P47870 7/20 0.47
GABRB3 P28472 3/20 0.45
GABRP O00591 2/20 0.45
GABRD O14764 2/20 0.45
GABRA1 P14867 2/20 0.45
GABRB1 P18505 2/20 0.45
GABRG2 P18507 2/20 0.45
GABRA5 P31644 2/20 0.45
GABRA3 P34903 2/20 0.45
GABRA4 P48169 2/20 0.45
GABRE P78334 2/20 0.45
GABRA6 Q16445 2/20 0.45
GABRG1 Q8N1C3 2/20 0.45
GABRG3 Q99928 2/20 0.45
GABRQ Q9UN88 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8666128 0.82 GABRB3 (0.47) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL6867229 0.82 GABRA2 (0.47) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL8659811 0.81 GABRA2 (0.44) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL6865370 0.78 GABRA2 (0.43) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL8662638 0.78 GABRA2 (0.43) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL9703393 0.78 GABRA2 (0.43) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL8663432 0.76 GABRA2 (0.41) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL6975907 0.74 GABRA2 (0.48) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL8661139 0.74 GABRA2 (0.40) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL7713255 0.73 GABRA2 (0.50) GABRA2GABRB2GABRB3GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812241-B2 FOR PLANTS, HUMANS, VETERINARY MEDICINE PFIZER INC. 2004-11-02 US disclosed
US-20030130307-A1 Heterocycles BANKS BERNARD JOSEPH (GB) 2003-07-10 US disclosed
US-6525079-B2 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole PFIZER INC. 2003-02-25 US disclosed
US-20010005725-A1 Heterocycles BANKS BERNARD JOSEPH (GB) 2001-06-28 US disclosed
US-6110958-A PARASITICIDES PFIZER INC. (US) 2000-08-29 US disclosed
US-6083965-A ANTIPARASITIC AGENTS PFIZER INC (US) 2000-07-04 US disclosed
EP-0957094-A1 1-(2-Halogenaryl)azoles as antiparasitic agents PFIZER INC. (US) 1999-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130307-A1 Heterocycles CYP1A1, CYP2E1, CYP1B1 GABRA2 2526/4885GABRB2 1986/4885GABRB3 2239/4885
US-20010005725-A1 Heterocycles CYP1A1, CYP2E1, CYP1B1 GABRA2 2526/4885GABRB2 1986/4885GABRB3 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.